Cargando…
Commentary: Composite cognitive and functional measures for early stage Alzheimer's disease trials
In this commentary I consider the issues raised in Schneider and Goldberg's review of composite cognitive and functional measures. I find much to agree with in their commentary and especially their concerns regarding satisfactory psychometric validation of composite measures. I endorse also the...
Autor principal: | Harrison, John E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819351/ https://www.ncbi.nlm.nih.gov/pubmed/33521231 http://dx.doi.org/10.1002/dad2.12009 |
Ejemplares similares
-
Commentary on Composite cognitive and functional measures for early stage Alzheimer's disease trials
por: Rentz, Dorene M., et al.
Publicado: (2020) -
Response to peer commentaries: Composite cognitive and functional measures for early stage Alzheimer's disease trials
por: Schneider, Lon S., et al.
Publicado: (2020) -
Composite cognitive and functional measures for early stage Alzheimer's disease trials
por: Schneider, Lon S., et al.
Publicado: (2020) -
Response to Schneider and Goldberg “Composite cognitive and functional measures for early stage Alzheimer's disease trials”
por: Sano, Mary, et al.
Publicado: (2020) -
Measuring cognition and function in the preclinical stage of Alzheimer's disease
por: Weintraub, Sandra, et al.
Publicado: (2018)